返回
Primary hepatic angiosarcoma
DOI:10.1016/j.ejso.2015.04.022.png)
摘要
En 中文
Primary hepatic angiosarcoma is a rare, aggressive tumor; composed of spindle or pleomorphic cells that line, or grow into, the lumina of pre-existing vascular spaces like sinusoids and terminal hepatic venules; with only about 200 cases diagnosed annually worldwide but it is the most common primary malignant mesenchymal tumor of the liver in adults and accounts for 2% of all primary hepatic malignancies. HAS occurs in association with known chemical carcinogens, but 75% of the tumors have no known etiology. Patients present with vague symptoms like abdominal pain, weight loss, fatigue or an abdominal mass. Hepatic angiosarcoma is usually multicentric and involves both lobes, entire liver may also found to be involved. CD31 is the most reliable marker. These tumors lack specific features on imaging, so, pathological diagnosis is necessary. There are no established treatment guidelines because of low frequency and aggressive nature of tumor, chemotherapy is only palliative, liver resection is indicated for solitary mass and liver transplant is contraindicated. The aim of this article is to comprehensively review all the available literature and to present detailed information and an update on primary hepatic angiosarcoma. (C) 2015 Elsevier Ltd. All rights reserved.
Keyword:
Primary hepatic angiosarcoma
Non-specific symptoms
Difficult and delayed diagnosis
No treatment guidelines
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
2.9
论文数:
6.7K
被引数:
1.3W
机构
引用论文
Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma
ANNALS OF ONCOLOGY
IF65.4
Relationship of Prostate-Specific Antigen Velocity to Histologic Findings in a Prostate Cancer Screening Program
Urology
IF0
O-acetylation of typhoid capsular polysaccharide confers polysaccharide rigidity and immunodominance by masking additional epitopes
Vaccine
IF0

